WEGOVY

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: c4c8b817064707f9
Drug Approval Canada Name: WEGOVY
Product Name: WEGOVY
Status: Marketed
Status Date: 2024-04-22
Original Market Date: 2024-04-22
Din: 02528541
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 68:20.06
Atc Original: A10BJ06 SEMAGLUTIDE
Atc Name: a 10 bj 06
Aig Number: 0159870003
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

SEMAGLUTIDE

9.6 MG / 3 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c4c8b817064707f9

Type

Standard